Society Information

Chinese Medical Association (CMA) is a non-profit national academic organization in China. It is an important social force in the development of medical science and technology and a linkage between the government and the medical professionals. The CMA, established in 1915, now has more than 80 specialty societies and 500,000 members in China.

Major functions of the CMA include: organizing domestic and international medical exchange activities; discovering, recommending and cultivating medical talents; editing and publishing more than 100 medical and popular science journals and over 100 audio-visual products; carrying out continuing medical education projects and specialists training programs; implementing medical projects evaluations and reviews, and assessment of decisions concerning science and technology projects; selecting and presenting awards for outstanding achievements in medical science and technology; promoting transformation and practical application of medical research results; disseminating medical and health knowledge for the general public; organizing technical appraisement on medical malpractice and AEFI (Adverse Events Following Immunization); undertaking the functions and missions entrusted by the government, and relaying suggestions and requests from the medical professionals to the government.

Chinese Portal Hypertension Alliance (CHESS) is dedicated to developing a world-class platform for clinical research and translational science on portal hypertension and cirrhosis.

The mission of CHESS is to conduct cutting-edge technology research and their translation and application about portal hypertension and cirrhosis. CHESS has initiated and led twenty-five multicenter clinical researches worldwide, with the support of over five hundred hospitals in China.

Portal Hypertension & Cirrhosis, the official journal of CHESS, was launched on December 6, 2021. It is the first international journal that focuses on portal hypertension and cirrhosis.